Clinical Trials Logo

Tympanic Membrane Perforation clinical trials

View clinical trials related to Tympanic Membrane Perforation.

Filter by:
  • Withdrawn  
  • Page 1

NCT ID: NCT03904316 Withdrawn - Clinical trials for Tympanic Membrane Perforation

Use of Biodesign® Otologic Graft in Tympanoplasty

Start date: October 3, 2018
Phase: Phase 4
Study type: Interventional

This is a prospective, randomized trial to evaluate tympanoplasty outcomes using Biodesign SIS graft compared to autologous temporalis fascia, the most commonly used graft for repair of tympanic membrane.

NCT ID: NCT03271970 Withdrawn - Clinical trials for Conductive Hearing Loss

The Anatomic Determinants of Perforation Induced Hearing Loss

Start date: April 2017
Phase: N/A
Study type: Observational

The purpose of this study is to identify factors that may contribute to conductive hearing loss. Conductive hearing loss is a type that is due to a problem with the outer or middle ear. Because of this, sound does not travel through the ear normally. Perforated tympanic membranes of study patients will be photographed during the patient's routine visit using a digital otoscope. These pictures will be used to analyze perforation size as an absolute value as well as a percentage of the tympanic membrane. Audiometric results and CT scans of temporal bone (reports and images) collected as standard of care will be evaluated. Images of CT scans will be imported into a medical imaging software for creation of anatomically realistic 3D models of the middle ear and mastoid air space. Structural analysis on each 3D model will be conducted and analyzed, the volume of middle ear and mastoid air spaces will be recorded, and data points will be correlated with perforation size and location to audiogram results.

NCT ID: NCT03028272 Withdrawn - Clinical trials for Tympanic Membrane Perforation

Hearing Results and Post Surgical Outcomes Using Amniotic Membrane Allograft vs. Fascia for Tympanoplasty

Start date: January 1, 2017
Phase: N/A
Study type: Interventional

The trial seeks to provide evidence that the Skye ActiveBarrier provides similar surgical and functional outcomes as fascia when used for tympanoplasties while offering benefits including reduced operative time, better patient satisfaction, and fewer complications.